Advertisement

Obesity Surgery

, Volume 29, Issue 10, pp 3212–3219 | Cite as

Laparoscopic Magenstrasse and Mill Gastroplasty (M&M): Midterm Results

  • Maud NeubergEmail author
  • Pierre-Arnaud Wuidar
  • Laurent Kohnen
  • Jenny Deflines
  • Nikos Kotzampassakis
  • Martine Demarche
  • Arnaud De Roover
Original Contributions
  • 92 Downloads

Abstract

Background

The Magenstrasse and Mill gastroplasty (M&M) is a gastric restrictive procedure without band or stomach resection. Short-term evaluation of the laparoscopic procedure showed low morbidity and satisfactory results on weight loss. Evidence of the validity of the technique in the longer term is scarce.

Methods

Data from patients who underwent M&M procedure from May 2012 to September 2015 were retrospectively reviewed. Preoperative clinical characteristics and data up to 4 years after operation were analyzed.

Results

A total of 132 patients were included in this study with a mean age of 46 ± 13.4 years. The mean body mass index (BMI) at the time of procedure was 43 ± 4.5 kg/m2. Mean percentage of excess weight loss (%EWL) was 67, 67, 58, and 57% at 1, 2, 3, and 4 years, respectively. The remission rate for diabetes was 36%. About half of the insulin-dependent patients could stop their insulin treatment. Hypertension was resolved in 33.8% of the patients after 4 years. Incidence of vitamin and mineral deficiency was low throughout the study period, less than or equal to 3% for vitamin B12 and 1% for ferritin. Incidence of gastroesophageal reflux did not exceed 15% during the study. Over 75% of the patients reported a good or very good quality of life following the surgery.

Conclusion

These results confirm the validity of M&M as a bariatric procedure. The low incidence of vitamin deficiencies and gastroesophageal reflux might be the important asset of M&M over other existing techniques.

Keywords

Laparoscopic Sleeve Gastroplasty Magenstrasse and Mill Obesity Surgery 

Notes

Compliance with Ethical Standards

The authors declare that they have no conflict of interest.

Ethical Approval

For this type of study, formal consent is not required.

References

  1. 1.
    Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta- analysis of randomised controlled trials. BMJ. 2013;347:f5934.CrossRefGoogle Scholar
  2. 2.
    Banerjee A, Ding Y, Mikami DJ, et al. The role of dumping syndrome in weight loss after gastric bypass surgery. Surg Endosc. 2013;27:1573–8.CrossRefGoogle Scholar
  3. 3.
    Iannelli A, Facchiano E, Gugenheim J. Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2006;16:1265–71.CrossRefGoogle Scholar
  4. 4.
    Khorgami Z, Shoar S, Andalib A, et al. Trends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates. Surg Obes Relat Dis. 2017;13:774–8.CrossRefGoogle Scholar
  5. 5.
    Trastulli S, Desiderio J, Guarino S, et al. Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis. 2013;9:816–29.CrossRefGoogle Scholar
  6. 6.
    Fischer L, Hildebrandt C, Bruckner T, et al. Excessive weight loss after sleeve gastrectomy: a systematic review. Obes Surg. 2012;22:721–31.CrossRefGoogle Scholar
  7. 7.
    Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23:1994–2003.CrossRefGoogle Scholar
  8. 8.
    Pellitero S, Martínez E, Puig R, et al. Evaluation of vitamin and trace element requirements after sleeve gastrectomy at long term. Obes Surg. 2017 Jul;27:1674–82.CrossRefGoogle Scholar
  9. 9.
    Oor JE, Roks DJ, Ünlü Ç, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016 Jan;211:250–67.CrossRefGoogle Scholar
  10. 10.
    Villagrán R, Smith G, Rodriguez, et al. Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy: incidence, analysis and follow-up in 1236 consecutive cases. Obes Surg. 2016;26:2555–61.CrossRefGoogle Scholar
  11. 11.
    Johnston D, Dachtler J, Sue-Ling HM, et al. The Magenstrasse and Mill operation for morbid obesity. Obes Surg. 2003;13:10–6.CrossRefGoogle Scholar
  12. 12.
    De Roover A, Kohnen L, Deflines J, et al. Laparoscopic Magenstrasse and Mill gastroplasty: first results of a prospective study. Obes Surg. 2015;25:234–41.CrossRefGoogle Scholar
  13. 13.
    Oria HE, Moorehead MK. Bariatric analysis and reporting outcome system (BAROS). Obes Surg. 1998;8:487–99.CrossRefGoogle Scholar
  14. 14.
    Carmichael AR, Johnston D, Bury RF, et al. Gastric emptying after a new, more physiological anti-obesity operation: the Magenstrasse and Mill procedure. Eur J Nucl Med. 2001;28(9):1379–83.CrossRefGoogle Scholar
  15. 15.
    Carmichael AR, Johnston D, King RF, et al. Effects of the Magenstrasse and Mill operation for obesity on plasma leptin and insulin resistance. Diabetes Obes Metab. 2001;3:99–103.CrossRefGoogle Scholar
  16. 16.
    Wang Y, Yi XY, Gong LL, et al. The effectiveness and safety of laparoscopic sleeve gastrectomy with different sizes of bougie calibration : a systematic review and meta-analysis. Int J Surg. 2018;49:32–8.CrossRefGoogle Scholar
  17. 17.
    Ghio B, Jiménez A, Corcelles R, et al. Midterm effects of bariatric surgery in patients with insulin-treated type 2 diabetes. Surg Obes Relat Dis. 2017;13:2004–9.CrossRefGoogle Scholar
  18. 18.
    Holter MM, Dutia R, Stano SM, et al. Glucose metabolism after gastric banding and gastric bypass in individuals with type 2 diabetes: weight loss effect. Diabetes Care. 2017;40:7–15.CrossRefGoogle Scholar
  19. 19.
    G L, Xu C, Campo RE, et al. Predictors of short-term diabetes remission after laparoscopic Roux-enY gastric bypass. Obes Surg. 2015;25:782–7.CrossRefGoogle Scholar
  20. 20.
    Park JY, Kim YJ. Prediction of diabetes remission in morbidly obese patients after Roux-en-Y gastric bypass. Obes Surg. 2016;26:749–56.CrossRefGoogle Scholar
  21. 21.
    Souteiro P, Belo S, Neves JS, et al. Preoperative beta cell function is predictive of diabetes remission after bariatric surgery. Obes Surg. 2017;27:288–94.CrossRefGoogle Scholar
  22. 22.
    Wang GF, Yan YX, Xu N, et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg. 2015;25:199–208.CrossRefGoogle Scholar
  23. 23.
    Ruiz-Tovar J, Llavero, C, Zubiaga, et al. Maintenance of multivitamin supplements after sleeve gastrectomy. Obes Surg 2016;26:2324–2330.CrossRefGoogle Scholar
  24. 24.
    Viscido G, Gorodner V, Signorini F, et al. Laparoscopic sleeve gastrectomy: endoscopic findings and gastroesophageal reflux symptoms at 18-month follow-up. J Laparoendosc Adv Surg Tech A. 2018;28(1):71–7.CrossRefGoogle Scholar
  25. 25.
    Althuwaini S, Bamehriz F, Aldohayan, et al. Prevalence and predictors of gastroesophageal reflux disease after laparoscopic sleeve gastrectomy. Obes Surg. 2018;28:916–22.CrossRefGoogle Scholar
  26. 26.
    Coupaye M, Gorbatchef C, Calabrese D, et al. Gastroesophageal reflux after sleeve gastrectomy: a prospective mechanistic study. Obes Surg. 2018;28(3):838–45.CrossRefGoogle Scholar
  27. 27.
    Carmichael AR, Sue-Ling HM, Johnston D. Quality of life after the Magenstrasse and Mill procedure for morbid obesity. Obes Surg. 2001;11:708–15.CrossRefGoogle Scholar
  28. 28.
    Ece I, Yilmaz H, Alptekin H, et al. Port site hernia after laparoscopic sleeve gastrectomy: a retrospective cohort study of 352 patients. Updat Surg. 2018;70:91–5.CrossRefGoogle Scholar
  29. 29.
    Scozzari G, Toppino M, Famiglietti F, et al. 10-year follow-up of laparoscopic vertical banded gastroplasty. Good results in selected patients. Ann Surg. 2010;252:831–9.CrossRefGoogle Scholar
  30. 30.
    Suter M, Jayet C, Jayet A. Vertical banded gastroplasty: long term results comparing three different techniques. Obes Surg. 2000;10:41–6.CrossRefGoogle Scholar
  31. 31.
    De Lartigue G, Diepenbroek C. Novel developments in vagal afferent nutrient sensing and its role in energy homeostasis. Curr Opin Pharmacol. 2016;31:38–43.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Abdominal Surgery and TransplantationCentre Hospitalier Universitaire de LiègeLiègeBelgium
  2. 2.Department of DiabetologyCentre Hospitalier Universitaire de LiègeLiègeBelgium
  3. 3.Department of Abdominal And Pediatric SurgeryCentre Hospitalier Régional de la CitadelleLiègeBelgium

Personalised recommendations